Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients

Benoît Mâsse^{1

2}, Nancy Robitaille^{3

4

5}, Jacques Lacroix^{3

4}

Affiliations

¹ Université de Montréal, Montreal, Quebec, Canada.
² Unité de Recherche Clinique Appliquée, Direction de la Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada.
³ Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
⁴ Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
⁵ Transfusion Medicine, Héma-Québec, Montreal, Quebec, Canada.

Editorial

Benoît Mâsse et al. JAMA. 2022.

. 2022 Jan 11;327(2):124-125.

doi: 10.1001/jama.2021.21890.

Benoît Mâsse^{1

2}, Nancy Robitaille^{3

4

5}, Jacques Lacroix^{3

4}

¹ Université de Montréal, Montreal, Quebec, Canada.
² Unité de Recherche Clinique Appliquée, Direction de la Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada.
³ Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada.
⁴ Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.
⁵ Transfusion Medicine, Héma-Québec, Montreal, Quebec, Canada.

No abstract available

Comment on

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. Goldenberg NA, et al. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. JAMA. 2022. PMID: 35015038 Free PMC article. Clinical Trial.